Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients

Journal of Immunology

Volumn 160, Issue 8, 1998, Pages 4106-4113

  Antonysamy, Mary A ^a   Steptoe, Raymond J ^a   Khanna, Ajai ^a   Rudert, William A ^b   Subbotin, Vladimir M ^a   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CONTROLLED STUDY; DENDRITIC CELL; DONOR; GRAFT FAILURE; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MICROCHIMERISM; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; T LYMPHOCYTE;

ANIMALS; BASE SEQUENCE; BONE MARROW TRANSPLANTATION; CHIMERA; DNA PRIMERS; GENES, MHC CLASS II; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TACROLIMUS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, ISOGENEIC;

EID: 0032522854     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Starzl, T. E., A. J. Demetris, N. Murase, S. Ildstad, C. Ricordi, and M. Trucco. 1992. Cell migration, chimerism, and graft acceptance. Lancet 339:1579.
2. Starzl, T. E., A. J. Demetris, M. Trucco, N. Murase, C. Ricordi, S. Ildstad, H. Ramos, S. Tod, A. Tzakis, J. J. Fung, M. Nalesnik, A. Zeevi, W. A. Rudert, and M. Kocova. 1993. Cell migration and chimerism after whole organ transplantation: the basis of graft acceptance. Hepatology 17:1127.
3. Starzl, T. E., A. J. Demetris, N. Murase, M. Trucco, A. W. Thomson, and A. S. Rao. 1996. The lost chord: microchimerism and allograft survival. Imnumol. Today 17:577.
4. Alard, P., J. A. Matriano, S. Socarras, M. A. Ortega, and J. W. Streilein. 1995. Detection of donor-derived cells by polymerase chain reaction in neonatally tolerant mice: microchimerism fails to predict tolerance. Transplantation 60:1125.
5. Qian, S., A. J. Demetris, N. Murase, A. S. Rao, J. J. Fung, and T. E. Starzl. 1994. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 19:916.
6. Demetris, A. J., N. Murase, S. Fujisaki, J. J. Fung, A. S. Rao, and T. E. Starzl. 1993. Hematolymphoid cell trafficking, microchimerism, and GVHD reactions after liver, bone marrow, and heart transplantation. Transplant. Proc. 25:3337.
7. Lu, L., W. A. Rudert, S. Qian, D. McCaslin, F. Fu, A. S. Rao, M. Trucco, J. J. Fung, T. E. Starzl, and A. W. Thomson. 1995. Growth of donor-derived dendritic cells from the bone marrow of liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 182:379.
8. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
9. Thomson, A. W., L. Lu, N. Murase, A. J. Demetris, A. S. Rao, and T. E. Starzl. 1995. Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 13:622.
10. Steptoe, R. J., and A. W. Thomson. 1996. Dendritic cells and tolerance induction. Clin. Exp. Immunol. 105:397.
11. Fontes, P., A. S. Rao, A. J. Demetris, A. Zeevi, M. Trucco, P. Carroll, W. Rybka, W. A. Rudert, C. Ricordi, F. Dodson, R. Shapiro, A. Tzakis, S. Todo, K. Abu-Elmagd, M. Jordan, J. J. Fung, and T. E. Starzl. 1994. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 344:151.
12. Shapiro, R., A. S. Rao, P. Fontes, M. Jordan, V. P. Scantlebury, C. Vivas, Combined kidney/bone marrow transplantation: evidence of augmentauon of chimerism. Transplantation 59:306.
13. Tsaroucha, A. K., C. Ricordi, T. A. Noto, N. S. Kenyon, R. Garcia-Morales, J. R. Nery, J. Miller, and A. G. Tzakis. 1997. Donor peripheral blood stem cell infusions in recipients of living-related liver allografts. Transplantation 64:362.
14. Lyman, S. D., L. James, T. V. Bos, P. deVries, K. Brasel, B. Gliniak, L. T. Hollingsworth, S. Picha, H. J. McKenna, R. R. Splett, F. A. Fletcher, E. Maraskovsky, T. Farrah, D. Foxworthe, D. E. Williams, and M. P. Beckmann. 1993. Molecular cloning of a ligand for the flt3/flk2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 75:1157.
15. Lyman, S. D., L. James, L. Johnson, K. Brasel, P. de Vries, S. S. Escobar, H. Downey, R. R. Splett, P. Beckmann, and H. J. McKenna. 1994. Cloning of the human monologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 83:2795.
16. Brasel, K., H. J. McKenna, P. J. Morrisey, K. Charrier, A. E. Morris, C. C. Lee, D. E. Williams, and S. D. Lyman. 1996. Hematological effects of flt-3 ligand in vivo in mice. Blood 88:2004.
17. Matthews, W., C. T. Jordan, G. W. Wiegand, D. Pardoll, and I. R. Lemischka. 1991. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65:1143.
18. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc. Natl. Acad. Sci. USA 91:459.
19. Galy, A., M. Travis, and B. Cen. 1995. Human T, B, natural killer, and dendritic cell arise from a common bone marrow progenitor cell subset. Immunity 3:459.
20. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt-3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953.
21. Pulendran, B., J. Lingappa, M. K. Kennedy, J. Smith, M. Teepe, A. Rudensky, C. R. Maliszewski, and E. Maraskovsky. 1997. Developmental pathways of dendritic cells in vivo: distinct function, phenotype and localization of dendritic cell subsets in flt3 ligand-treated mice. J. Immunol. 159:2222.
22. Steptoe, R. J., F. Fu, W. Li, M. L. Drakes, L. Lu, A. J. Demetris, S. Qian, H. J. McKenna, and A. W. Thomson. 1997. Augmentation of dendritic cells in murine organ donors by flt-3 ligand alters the balance between transplant tolerance and immunity. J. Immunol. 159:5483.
23. Drakes, M. L., L. Lu, V. M. Subbotin, and A. W. Thomson. 1997. In vivo administration of flt3 ligand markedly stimulates generation of dendritic cell progenitors from mouse liver. J. Immunol. 159:4268.
24. Lynch, D. A., A. Andreasen, E. Maraskovsky, J. Whitmore, R. E. Miller, and J. C. L. Schuh. 1997. Flt3 ligand induces tumor regression and anti-tumor immune responses in vivo. Nat. Med. 3:625.
25. Fulmer, R. I., A. T. Cramer, R. A. Liebelt, and A. G. Liebelt. 1963. Transplantation of cardiac tissue into the mouse ear. Am. J. Anat. 113:273.
26. Lu, L., J. Woo, A. S. Rao, Y. Li, S. C. Watkins, S. Qian, T. E. Starzl, A. J. Demetris, and A. W. Thomson. 1994. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J. Exp. Med. 179:1823.
27. Ricordi, C., T. Karatzas, J. Nery, M. Webb, G. Selvaggi, L. Fernandez, F. A. Khan, P. Rutz, E. Schiff, L. Olson, H. Fernandez, J. Bean, V. Esquenazi, J. Miller, and A. G. Tzakis. 1997. High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing. Transplantation 63:7.
28. Thomson, A. W., L. Lu, V. M. Subbotin, Y. Li, S. Qian, A. S. Rao, J. J. Fung, and T. E. Starzl. 1995. In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Transplantation 59: 544.
29. Thomson, A. W., L. Lu, Y. Wan, S. Qian, C. P. Larsen, and T. E. Starzl. 1996. Identification of donor-derived dendritic cell progenitors in bone marrow of spontaneously tolerant liver allograft recipients. Transplantation 60:1.
30. Matzinger, P., and S. Guerdner. 1989. Does T-cell tolerance require an antigen-presenting cell? Nature 338:74.
31. Saleem, M., G. J. Sawyer, R. A. Schofield, N. D. Seymour, K. Gustafsson, and J. W. Fabre. 1997. Discordant expression of major histocompatibility complex class II antigens and invariant chain in interstitial dendritic cells. Transplantation 63:1134.
32. Inaba, K., M. Pack, M. Inaba, H. Sakuta, F. Isdell, and R. M. Steinman. 1997. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J. Exp. Med. 186:665.
33. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 60:1539.
34. -) prolong cardiac allograft survival in non-immunosuppressed recipients. Transplantation 62:659.
35. Rastellini, C., L. Lu, C. Ricordi, T. E. Starzl, A. S. Rao, and A. W. Thomson. 1995. GM-CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 60:1366.
36. Suss, G., and K. Shortman. 1996. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183:1789.
37. Lu, L., S. Qian, P. Hershberger, W. A. Rudert, D. H. Lynch, and A. W. Thomson. 1997. Fas ligand (CD95L) and B7 expression on dendritic cells provide counterregulatory signals for T cell survival and proliferation. J. Immunol. 158:5676.
38. Dahmen, U., S. Qian, A. S. Rao, A. J. Demetris, F. Fu, H. Sun, L. Gao, J. J. Fung, and T. E. Starzl. 1994. Split tolerance induced by orthotopic liver transplantation in mice. Transplantation 58:1.
39. Starzl, T. E., A. J. Demetris, N. Murase, A. W. Thomson, M. Trucco, and C. Ricordi. 1993. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol. Today 14:326.